Systemic blockade of ACVR2B ligands prevents chemotherapy-induced muscle wasting by restoring muscle protein synthesis without affecting oxidative capacity or atrogenes

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

(2016) Daniel J Klionsky et al.   Autophagy

Bone and skeletal muscle: Key players in mechanotransduction and potential overlapping mechanisms

(2015) Craig A. Goodman et al.   BONE

Bone and muscle: Interactions beyond mechanical

(2015) Marco Brotto et al.   BONE

Muscle hypertrophy induced by myostatin inhibition accelerates degeneration in dysferlinopathy

(2015) Yun-Sil Lee et al.   HUMAN MOLECULAR GENETICS

Complete reversal of muscle wasting in experimental cancer cachexia: Additive effects of activin type II receptor inhibition and β-2 agonist

(2015) Míriam Toledo et al.   INTERNATIONAL JOURNAL OF CANCER

Increased mitochondrial emission of reactive oxygen species and calpain activation are required for doxorubicin-induced cardiac and skeletal muscle myopathy

(2015) Kisuk Min et al.   JOURNAL OF PHYSIOLOGY-LONDON

IRE1α-Dependent Decay of CReP/Ppp1r15b mRNA Increases Eukaryotic Initiation Factor 2α Phosphorylation and Suppresses Protein Synthesis

(2015) Jae-Seon So et al.   MOLECULAR AND CELLULAR BIOLOGY

Myostatin/activin blocking combined with exercise reconditions skeletal muscle expression profile of mdx mice

(2015) Heikki Kainulainen et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Muscle wasting in disease: molecular mechanisms and promising therapies

(2015) Shenhav Cohen et al.   NATURE REVIEWS DRUG DISCOVERY

Anthracycline-containing chemotherapy causes long-term impairment of mitochondrial respiration and increased reactive oxygen species release in skeletal muscle

(2015) Gilles Gouspillou et al.   Scientific Reports

Acylated and unacylated ghrelin inhibit doxorubicin-induced apoptosis in skeletal muscle

(2014) A. P. Yu et al.   Acta Physiologica

Concomitant low-dose doxorubicin treatment and exercise

(2014) Kathleen Sturgeon et al.   AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY

Characterization of Anthropometric Changes that Occur During Neoadjuvant Therapy for Potentially Resectable Pancreatic Cancer

(2014) Amanda B. Cooper et al.   ANNALS OF SURGICAL ONCOLOGY

Activation of ERK by sodium tungstate induces protein synthesis and prevents protein degradation in rat L6 myotubes

(2014) Rafael Salto et al.   FEBS LETTERS

Prevention of Anthracycline-Induced Cardiotoxicity

(2014) Pimprapa Vejpongsa et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Blockade of ActRIIB Signaling Triggers Muscle Fatigability and Metabolic Myopathy

(2014) Karima Relizani et al.   MOLECULAR THERAPY

Muscle Atrophy in Response to Cytotoxic Chemotherapy Is Dependent on Intact Glucocorticoid Signaling in Skeletal Muscle

(2014) Theodore P. Braun et al.   PLoS One

Exercise restores decreased physical activity levels and increases markers of autophagy and oxidative capacity in myostatin/activin-blocked mdx mice

(2013) Juha J. Hulmi et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

A myostatin and activin decoy receptor enhances bone formation in mice

(2013) P. Bialek et al.   BONE

Elevated expression of activins promotes muscle wasting and cachexia

(2013) Justin L. Chen et al.   FASEB JOURNAL

The anticancer agent doxorubicin disrupts mitochondrial energy metabolism and redox balance in skeletal muscle

(2013) Laura A.A. Gilliam et al.   FREE RADICAL BIOLOGY AND MEDICINE

Regulation of muscle protein synthesis and the effects of catabolic states

(2013) Bradley S. Gordon et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Voluntary Wheel Running in Growing Rats Does Not Protect Against Doxorubicin-induced Osteopenia

(2013) Reid Hayward et al.   JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY

The effects of acute doxorubicin treatment on proteome lysine acetylation status and apical caspases in skeletal muscle of fasted animals

(2013) Amie J. Dirks-Naylor et al.   Journal of Cachexia Sarcopenia and Muscle

Muscle protein synthesis, mTORC1/MAPK/Hippo signaling, and capillary density are altered by blocking of myostatin and activins

(2012) Juha J. Hulmi et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Development of doxorubicin-induced chronic cardiotoxicity in the B6C3F1 mouse model

(2012) Varsha G. Desai et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Doxorubicin acts via mitochondrial ROS to stimulate catabolism in C2C12 myotubes

(2011) Laura A. A. Gilliam et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

Altered REDD1, myostatin, and Akt/mTOR/FoxO/MAPK signaling in streptozotocin-induced diabetic muscle atrophy

(2011) Juha J. Hulmi et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Chemotherapy-Induced Weakness and Fatigue in Skeletal Muscle: The Role of Oxidative Stress

(2011) Laura A.A. Gilliam et al.   ANTIOXIDANTS & REDOX SIGNALING

Chipster: user-friendly analysis software for microarray and other high-throughput data

(2011) M Aleksi Kallio et al.   BMC GENOMICS

Exercise protects against doxorubicin-induced oxidative stress and proteolysis in skeletal muscle

(2011) Ashley J. Smuder et al.   JOURNAL OF APPLIED PHYSIOLOGY

Exercise protects against doxorubicin-induced markers of autophagy signaling in skeletal muscle

(2011) Ashley J. Smuder et al.   JOURNAL OF APPLIED PHYSIOLOGY

Gene expression profiling of skeletal muscles treated with a soluble activin type IIB receptor

(2011) Fedik Rahimov et al.   PHYSIOLOGICAL GENOMICS

TNF/TNFR1 signaling mediates doxorubicin-induced diaphragm weakness

(2010) Laura A. A. Gilliam et al.   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

Reversal of Cancer Cachexia and Muscle Wasting by ActRIIB Antagonism Leads to Prolonged Survival

(2010) Xiaolan Zhou et al.   CELL

Novel insights into the regulation of skeletal muscle protein synthesis as revealed by a new nonradioactive in vivo technique

(2010) Craig A. Goodman et al.   FASEB JOURNAL

Muscle Wasting and Impaired Myogenesis in Tumor Bearing Mice Are Prevented by ERK Inhibition

(2010) Fabio Penna et al.   PLoS One

Network of vascular diseases, death and biochemical characteristics in a set of 4,197 patients with type 1 diabetes (The FinnDiane Study)

(2009) Ville-Petteri Mäkinen et al.   Cardiovascular Diabetology

Doxorubicin acts through tumor necrosis factor receptor subtype 1 to cause dysfunction of murine skeletal muscle

(2009) Laura A. A. Gilliam et al.   JOURNAL OF APPLIED PHYSIOLOGY

SUnSET, a nonradioactive method to monitor protein synthesis

(2009) Enrico K Schmidt et al.   NATURE METHODS

Mechanisms of Cancer Cachexia

(2009) Michael J. Tisdale   PHYSIOLOGICAL REVIEWS

Acute Doxorubicin Cardiotoxicity Is Associated With p53-Induced Inhibition of the Mammalian Target of Rapamycin Pathway

(2008) Wuqiang Zhu et al.   CIRCULATION